Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

AVIR vs GALT: stock comparison and AI forecast

Atea Pharmaceuticals, Inc. (AVIR) and Galectin Therapeutics Inc (GALT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

AVIR Atea Pharmaceuticals, Inc.

Market Cap
$334M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

GALT Galectin Therapeutics Inc

Market Cap
$336M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

AVIR · GALT

Key facts

  • AVIR and GALT have similar market capitalizations ($334M and $336M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricAVIRGALT
Market Cap$334M$336M
P/B Ratio1.64x–
EPS$-1.91$-0.50
Book Value/Share$2.55–

Profitability & Margins

MetricAVIRGALT
ROE-81.0%–
ROA-71.2%-187.8%
ROIC-89.9%11.4%
Tax Rate3.8%–

Financial Health

MetricAVIRGALT
Current Ratio8.13x0.10x
D/E Ratio0.14x–
Financial Leverage1.14x–
Interest Coverage–-9.2x
Working Capital$201M-$137M

Cash Flow

MetricAVIRGALT
Operating Cash Flow-$152M-$16M

Income Statement

MetricAVIRGALT
Operating Income-$184M-$16M
Net Income-$165M-$28M
R&D Expense$155M$9M

Dividend & Shareholder Information

MetricAVIRGALT
Shares Outstanding80M101M
FAQ

AVIR vs GALT: stock comparison and AI forecast

Which is bigger, AVIR or GALT?

AVIR and GALT have similar market capitalizations ($334M and $336M).

Which one does Intratio's AI model rank higher, AVIR or GALT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.